Current Volume 13(1) 2008 Supl. (48)

01 Jan 2008
Comparing graft function for tacrolimus- and cyclosporine-treated patients. A long-term comparative study involving nephrotoxicity markers
Z. Marchewka, J. Kuźniar
Ann Transplant 2008; 13(1): 43-43 :: ID: 880211

01 Jan 2008
Comparing graft function for tacrolimus- and cyclosporine-treated patients. A long-term comparative study involving nephrotoxicity markers
Z. Marchewka, J. Kuźniar, K. Falkiewicz, B. Szymańska, M. Zynek-Litwin, D. Patrzałek, A. Długosz, M. Klinger
Ann Transplant 2008; 13(1): 43-43 :: ID: 880211
564

01 Jan 2008
Drug lymphocyte level: New perspective in clinical immunosuppression monitoring
A. Barbari,
Ann Transplant 2008; 13(1): 43-43 :: ID: 880210

01 Jan 2008
Drug lymphocyte level: New perspective in clinical immunosuppression monitoring
A. Barbari
Ann Transplant 2008; 13(1): 43-43 :: ID: 880210
514

01 Jan 2008
Biomarkers assays for T-lymphocyte activation and proliferation applied in a multicenter clinical trial of AEB071 in renal transplantation
J. M. Kovarik, K. Budde
Ann Transplant 2008; 13(1): 42-42 :: ID: 880209

01 Jan 2008
Biomarkers assays for T-lymphocyte activation and proliferation applied in a multicenter clinical trial of AEB071 in renal transplantation
J. M. Kovarik, K. Budde, J. Steiger, J. M. Grinyo, F. Straube, A. Groenewegen, A. Vitalit, J. Geissler, J. Klupp, M. J. Barten
Ann Transplant 2008; 13(1): 42-42 :: ID: 880209
536

01 Jan 2008
Inosine monophosphate dehydrogenase (IMPDH) activity after mycophenolate mofetil (MMF) in renal transplant patients receiving different immunosuppressive combined therapy and stable after at least 3 months’ administration
L. R. Chiarelli, M. Molinaro
Ann Transplant 2008; 13(1): 42-42 :: ID: 880208

01 Jan 2008
Inosine monophosphate dehydrogenase (IMPDH) activity after mycophenolate mofetil (MMF) in renal transplant patients receiving different immunosuppressive combined therapy and stable after at least 3 months’ administration
L. R. Chiarelli, M. Molinaro, C. Libetta, C. Tinelli, L. Cosmai, G. Valentini, A. Dal Canton, M. Regazzi
Ann Transplant 2008; 13(1): 42-42 :: ID: 880208
544

01 Jan 2008
IMPDH activity on day 6 after kidney transplantation is signiï¬cantly related to the risk of acute rejection in MMF treated patients
F. Sombogaard, R.A.A. Mathot
Ann Transplant 2008; 13(1): 41-42 :: ID: 880207

01 Jan 2008
IMPDH activity on day 6 after kidney transplantation is signiï¬cantly related to the risk of acute rejection in MMF treated patients
F. Sombogaard, R.A.A. Mathot, P. Glander, W. Weimar, T. van Gelder
Ann Transplant 2008; 13(1): 41-42 :: ID: 880207
543

01 Jan 2008
Association between pharmacodynamic parameters and clinical events under therapy with EC-MPS in the early phase after kidney transplantation (KTx)
E. Wieland, M. Shipkova
Ann Transplant 2008; 13(1): 41-41 :: ID: 880206

01 Jan 2008
Association between pharmacodynamic parameters and clinical events under therapy with EC-MPS in the early phase after kidney transplantation (KTx)
E. Wieland, M. Shipkova, Y. Martius, G. Hasche, C. Klett, R. Bolley, C. Olbricht
Ann Transplant 2008; 13(1): 41-41 :: ID: 880206
516

01 Jan 2008
Tacrolimus – biotechnological prospects for a generic product
W. Gajzlerska, J. Turło
Ann Transplant 2008; 13(1): 40-41 :: ID: 880205

01 Jan 2008
Tacrolimus – biotechnological prospects for a generic product
W. Gajzlerska, J. Turło, B. Gutkowska, F. Herold
Ann Transplant 2008; 13(1): 40-41 :: ID: 880205
475

01 Jan 2008
Pharmacokinetics of mycophenolic acid and its phenyl-glucuronide in kidney transplant recipients with renal insufï¬ciency
M. Chrzanowska, J. Kamińska
Ann Transplant 2008; 13(1): 40-40 :: ID: 880204

01 Jan 2008
Pharmacokinetics of mycophenolic acid and its phenyl-glucuronide in kidney transplant recipients with renal insufï¬ciency
M. Chrzanowska, J. Kamińska, M. Głyda, N. Wachowiak
Ann Transplant 2008; 13(1): 40-40 :: ID: 880204
473

01 Jan 2008
Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?
H. Tesfaye, R. Prusa
Ann Transplant 2008; 13(1): 40-40 :: ID: 880203

01 Jan 2008
Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?
H. Tesfaye, R. Prusa, B. Jedlickova, J. Segethova
Ann Transplant 2008; 13(1): 40-40 :: ID: 880203
489

01 Jan 2008
Therapeutic Drug Monitoring of tacrolimus in renal transplant patients
B. Solnica, K. Słowińska-Solnica
Ann Transplant 2008; 13(1): 39-40 :: ID: 880202

01 Jan 2008
Therapeutic Drug Monitoring of tacrolimus in renal transplant patients
B. Solnica, K. Słowińska-Solnica, E. Ignacak, J. W. Naskalski
Ann Transplant 2008; 13(1): 39-40 :: ID: 880202
493

01 Jan 2008
Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dose adaptation tool
J.E. Wallin, L. E. Friberg
Ann Transplant 2008; 13(1): 39-39 :: ID: 880201

01 Jan 2008
Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dose adaptation tool
J.E. Wallin, L. E. Friberg, A. Fasth, C. E. Staatz
Ann Transplant 2008; 13(1): 39-39 :: ID: 880201
523

01 Jan 2008
Conversion from tacrolimus twice a day formulation to once-daily tacrolimus in kidney transplant recipients
D. Kamińska, M. Kuriata-Kordek
Ann Transplant 2008; 13(1): 38-39 :: ID: 880200

01 Jan 2008
Conversion from tacrolimus twice a day formulation to once-daily tacrolimus in kidney transplant recipients
D. Kamińska, M. Kuriata-Kordek, M. Boratyńska, K. Falkiewicz, M. Klinger
Ann Transplant 2008; 13(1): 38-39 :: ID: 880200
642

01 Jan 2008
Evaluating co-medication and matrix interference influence on ion yields: A key step in therapeutic drug monitoring HPLC-MS/MS assay validation
C. Seger, M. Bock
Ann Transplant 2008; 13(1): 38-38 :: ID: 880198

01 Jan 2008
Evaluating co-medication and matrix interference influence on ion yields: A key step in therapeutic drug monitoring HPLC-MS/MS assay validation
C. Seger, M. Bock, K. Tentschert, A. Griesmacher
Ann Transplant 2008; 13(1): 38-38 :: ID: 880198
468

01 Jan 2008
Comparison of tacrolimus levels obtained with twice-daily administration formulation (Prograf®) and with once-daily formulation (Advagraf®)
M. T. Rabuñal Ãlvarez, E. Fernández Gabriel
Ann Transplant 2008; 13(1): 38-38 :: ID: 880199

01 Jan 2008
Comparison of tacrolimus levels obtained with twice-daily administration formulation (Prograf®) and with once-daily formulation (Advagraf®)
M. T. Rabuñal Ãlvarez, E. Fernández Gabriel, M. Outeda MacÃas, I. MartÃn Herranz
Ann Transplant 2008; 13(1): 38-38 :: ID: 880199
485

01 Jan 2008
Evaluation of the Architect and Dimension tacrolimus and cyclosporine assays
P. Wallemacq, J. S. Gofï¬net
Ann Transplant 2008; 13(1): 37-38 :: ID: 880197

01 Jan 2008
Evaluation of the Architect and Dimension tacrolimus and cyclosporine assays
P. Wallemacq, J. S. Gofï¬net, H. Ait-Youcef
Ann Transplant 2008; 13(1): 37-38 :: ID: 880197
530

01 Jan 2008
Siemens Healthcare Diagnostics immunosuppressive drug monitoring solutions
T. Wei, N. Morjana
Ann Transplant 2008; 13(1): 37-37 :: ID: 880196

01 Jan 2008
Siemens Healthcare Diagnostics immunosuppressive drug monitoring solutions
T. Wei, N. Morjana, S. Goss, L. Bantum, Y. Yue, R. Janzen, G. Siefring
Ann Transplant 2008; 13(1): 37-37 :: ID: 880196
530

01 Jan 2008
Evaluation of a commercially available whole blood calibrator and control kit for the analysis of cyclosporin A, everolimus, sirolimus and tacrolimus using LC/MS/MS technology
A. M. Taylor, T. N. Gamble
Ann Transplant 2008; 13(1): 36-37 :: ID: 880195

01 Jan 2008
Evaluation of a commercially available whole blood calibrator and control kit for the analysis of cyclosporin A, everolimus, sirolimus and tacrolimus using LC/MS/MS technology
A. M. Taylor, T. N. Gamble, D. Blake, T. Drury, M. Ehrdhard
Ann Transplant 2008; 13(1): 36-37 :: ID: 880195
542

01 Jan 2008
High throughput LC-MS/MS method for quantitative analysis of immunosuppressant drugs in whole blood using a triple quadrupole LC-MS/MS with an APCI source and implemented on column multiplexing LC system
R. Ruzicka, M. Kozak
Ann Transplant 2008; 13(1): 36-36 :: ID: 880194

01 Jan 2008
High throughput LC-MS/MS method for quantitative analysis of immunosuppressant drugs in whole blood using a triple quadrupole LC-MS/MS with an APCI source and implemented on column multiplexing LC system
R. Ruzicka, M. Kozak, V. Bodepudi, R. Loor, J. Zonderman
Ann Transplant 2008; 13(1): 36-36 :: ID: 880194
515

01 Jan 2008
Sirolimus measurement by LC-MS/MS without solid phase extraction – overcoming the obstacles
N. W. Brown, P. Arampatzis
Ann Transplant 2008; 13(1): 36-36 :: ID: 880193

01 Jan 2008
Sirolimus measurement by LC-MS/MS without solid phase extraction – overcoming the obstacles
N. W. Brown, P. Arampatzis, C. E. Gonde, M. Pires, J. Tracey, M. Tredger
Ann Transplant 2008; 13(1): 36-36 :: ID: 880193
568

29 Sep 2008
The role of genetics and pharmacogenetic monitoring in transplantation
M. Masri,
Ann Transplant 2008; 13(1): 35-35 :: ID: 880192

29 Sep 2008
The role of genetics and pharmacogenetic monitoring in transplantation
M. Masri
Ann Transplant 2008; 13(1): 35-35 :: ID: 880192
531

01 Jan 2008
The CYP3A5*1/*3 single nucleotide polymorphism (SNP) determines the extent of drug interaction between tacrolimus and fluconazole in renal transplant recipients
H. de Jonge, M. Naesens
Ann Transplant 2008; 13(1): 34-35 :: ID: 880191

01 Jan 2008
The CYP3A5*1/*3 single nucleotide polymorphism (SNP) determines the extent of drug interaction between tacrolimus and fluconazole in renal transplant recipients
H. de Jonge, M. Naesens, Y. Vanrenterghem, D. R. Kuypers
Ann Transplant 2008; 13(1): 34-35 :: ID: 880191
522

01 Jan 2008
In vitro investigation of MRP 2 in the cyclosporine A – pravastatin interplay
R.l Kato, M. Nishide
Ann Transplant 2008; 13(1): 34-34 :: ID: 880190

01 Jan 2008
In vitro investigation of MRP 2 in the cyclosporine A – pravastatin interplay
R.l Kato, M. Nishide, C. Kodzu, Y. Ijiri, K. Tanaka
Ann Transplant 2008; 13(1): 34-34 :: ID: 880190
553

01 Jan 2008
In vivo hepatic CYP3A4 activity is signiï¬cantly higher in tacrolimus treated vs cyclosporine treated renal transplant recipients
H. de Jonge, M. Naesens
Ann Transplant 2008; 13(1): 34-34 :: ID: 880189

01 Jan 2008
In vivo hepatic CYP3A4 activity is signiï¬cantly higher in tacrolimus treated vs cyclosporine treated renal transplant recipients
H. de Jonge, M. Naesens, K. Verbeke, Y. Vanrenterghem, D. R. Kuypers
Ann Transplant 2008; 13(1): 34-34 :: ID: 880189
538

01 Jan 2008
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in caucasian liver transplant patients
A. Provenzani, M. Notarbartolo
Ann Transplant 2008; 13(1): 33-33 :: ID: 880188

01 Jan 2008
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in caucasian liver transplant patients
A. Provenzani, M. Notarbartolo, F. Biondi, M. Labbozzetta, P. Poma, G. Vizzini, U. Palazzo, P. Polidori, F. Triolo, B. Gridelli, N. D'Alessandro
Ann Transplant 2008; 13(1): 33-33 :: ID: 880188
483

01 Jan 2008
The pregnane X receptor C-25385t single nucleotide polymorphism (SNP) does not affect tacrolimus pharmacokinetics in a large cohort of renal transplant recipients
H. de Jonge, M. Naesens
Ann Transplant 2008; 13(1): 33-33 :: ID: 880187

01 Jan 2008
The pregnane X receptor C-25385t single nucleotide polymorphism (SNP) does not affect tacrolimus pharmacokinetics in a large cohort of renal transplant recipients
H. de Jonge, M. Naesens, Y. Vanrenterghem, D. R. Kuypers
Ann Transplant 2008; 13(1): 33-33 :: ID: 880187
628
Volume 13(1) 2008 Supl. (48) Supplement

01 Jan 2008 :
Comparing graft function for tacrolimus- and cyclosporine-treated patients. A long-term comparative study involving nephrotoxicity markers
Z. Marchewka, J. Kuźniar
Ann Transplant 2008; 13(1): 43-43 :: ID: 880211
564 0

01 Jan 2008 :
Comparing graft function for tacrolimus- and cyclosporine-treated patients. A long-term comparative study involving nephrotoxicity markers
Z. Marchewka, J. Kuźniar, K. Falkiewicz, B. Szymańska, M. Zynek-Litwin, D. Patrzałek, A. Długosz, M. Klinger
Ann Transplant 2008; 13(1): 43-43 :: ID: 880211
564 0

01 Jan 2008 :
Drug lymphocyte level: New perspective in clinical immunosuppression monitoring
A. Barbari,
Ann Transplant 2008; 13(1): 43-43 :: ID: 880210
514 0

01 Jan 2008 :
Drug lymphocyte level: New perspective in clinical immunosuppression monitoring
A. Barbari
Ann Transplant 2008; 13(1): 43-43 :: ID: 880210
514 0

01 Jan 2008 :
Biomarkers assays for T-lymphocyte activation and proliferation applied in a multicenter clinical trial of AEB071 in renal transplantation
J. M. Kovarik, K. Budde
Ann Transplant 2008; 13(1): 42-42 :: ID: 880209
536 0

01 Jan 2008 :
Biomarkers assays for T-lymphocyte activation and proliferation applied in a multicenter clinical trial of AEB071 in renal transplantation
J. M. Kovarik, K. Budde, J. Steiger, J. M. Grinyo, F. Straube, A. Groenewegen, A. Vitalit, J. Geissler, J. Klupp, M. J. Barten
Ann Transplant 2008; 13(1): 42-42 :: ID: 880209
536 0

01 Jan 2008 :
Inosine monophosphate dehydrogenase (IMPDH) activity after mycophenolate mofetil (MMF) in renal transplant patients receiving different immunosuppressive combined therapy and stable after at least 3 months’ administration
L. R. Chiarelli, M. Molinaro
Ann Transplant 2008; 13(1): 42-42 :: ID: 880208
544 0

01 Jan 2008 :
Inosine monophosphate dehydrogenase (IMPDH) activity after mycophenolate mofetil (MMF) in renal transplant patients receiving different immunosuppressive combined therapy and stable after at least 3 months’ administration
L. R. Chiarelli, M. Molinaro, C. Libetta, C. Tinelli, L. Cosmai, G. Valentini, A. Dal Canton, M. Regazzi
Ann Transplant 2008; 13(1): 42-42 :: ID: 880208
544 0

01 Jan 2008 :
IMPDH activity on day 6 after kidney transplantation is signiï¬cantly related to the risk of acute rejection in MMF treated patients
F. Sombogaard, R.A.A. Mathot
Ann Transplant 2008; 13(1): 41-42 :: ID: 880207
543 0

01 Jan 2008 :
IMPDH activity on day 6 after kidney transplantation is signiï¬cantly related to the risk of acute rejection in MMF treated patients
F. Sombogaard, R.A.A. Mathot, P. Glander, W. Weimar, T. van Gelder
Ann Transplant 2008; 13(1): 41-42 :: ID: 880207
543 0

01 Jan 2008 :
Association between pharmacodynamic parameters and clinical events under therapy with EC-MPS in the early phase after kidney transplantation (KTx)
E. Wieland, M. Shipkova
Ann Transplant 2008; 13(1): 41-41 :: ID: 880206
516 0

01 Jan 2008 :
Association between pharmacodynamic parameters and clinical events under therapy with EC-MPS in the early phase after kidney transplantation (KTx)
E. Wieland, M. Shipkova, Y. Martius, G. Hasche, C. Klett, R. Bolley, C. Olbricht
Ann Transplant 2008; 13(1): 41-41 :: ID: 880206
516 0

01 Jan 2008 :
Tacrolimus – biotechnological prospects for a generic product
W. Gajzlerska, J. Turło
Ann Transplant 2008; 13(1): 40-41 :: ID: 880205
475 0

01 Jan 2008 :
Tacrolimus – biotechnological prospects for a generic product
W. Gajzlerska, J. Turło, B. Gutkowska, F. Herold
Ann Transplant 2008; 13(1): 40-41 :: ID: 880205
475 0

01 Jan 2008 :
Pharmacokinetics of mycophenolic acid and its phenyl-glucuronide in kidney transplant recipients with renal insufï¬ciency
M. Chrzanowska, J. Kamińska
Ann Transplant 2008; 13(1): 40-40 :: ID: 880204
473 0

01 Jan 2008 :
Pharmacokinetics of mycophenolic acid and its phenyl-glucuronide in kidney transplant recipients with renal insufï¬ciency
M. Chrzanowska, J. Kamińska, M. Głyda, N. Wachowiak
Ann Transplant 2008; 13(1): 40-40 :: ID: 880204
473 0

01 Jan 2008 :
Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?
H. Tesfaye, R. Prusa
Ann Transplant 2008; 13(1): 40-40 :: ID: 880203
489 0

01 Jan 2008 :
Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?
H. Tesfaye, R. Prusa, B. Jedlickova, J. Segethova
Ann Transplant 2008; 13(1): 40-40 :: ID: 880203
489 0

01 Jan 2008 :
Therapeutic Drug Monitoring of tacrolimus in renal transplant patients
B. Solnica, K. Słowińska-Solnica
Ann Transplant 2008; 13(1): 39-40 :: ID: 880202
493 0

01 Jan 2008 :
Therapeutic Drug Monitoring of tacrolimus in renal transplant patients
B. Solnica, K. Słowińska-Solnica, E. Ignacak, J. W. Naskalski
Ann Transplant 2008; 13(1): 39-40 :: ID: 880202
493 0

01 Jan 2008 :
Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dose adaptation tool
J.E. Wallin, L. E. Friberg
Ann Transplant 2008; 13(1): 39-39 :: ID: 880201
523 0

01 Jan 2008 :
Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dose adaptation tool
J.E. Wallin, L. E. Friberg, A. Fasth, C. E. Staatz
Ann Transplant 2008; 13(1): 39-39 :: ID: 880201
523 0

01 Jan 2008 :
Conversion from tacrolimus twice a day formulation to once-daily tacrolimus in kidney transplant recipients
D. Kamińska, M. Kuriata-Kordek
Ann Transplant 2008; 13(1): 38-39 :: ID: 880200
642 0

01 Jan 2008 :
Conversion from tacrolimus twice a day formulation to once-daily tacrolimus in kidney transplant recipients
D. Kamińska, M. Kuriata-Kordek, M. Boratyńska, K. Falkiewicz, M. Klinger
Ann Transplant 2008; 13(1): 38-39 :: ID: 880200
642 0

01 Jan 2008 :
Evaluating co-medication and matrix interference influence on ion yields: A key step in therapeutic drug monitoring HPLC-MS/MS assay validation
C. Seger, M. Bock
Ann Transplant 2008; 13(1): 38-38 :: ID: 880198
468 0

01 Jan 2008 :
Evaluating co-medication and matrix interference influence on ion yields: A key step in therapeutic drug monitoring HPLC-MS/MS assay validation
C. Seger, M. Bock, K. Tentschert, A. Griesmacher
Ann Transplant 2008; 13(1): 38-38 :: ID: 880198
468 0

01 Jan 2008 :
Comparison of tacrolimus levels obtained with twice-daily administration formulation (Prograf®) and with once-daily formulation (Advagraf®)
M. T. Rabuñal Ãlvarez, E. Fernández Gabriel
Ann Transplant 2008; 13(1): 38-38 :: ID: 880199
485 0

01 Jan 2008 :
Comparison of tacrolimus levels obtained with twice-daily administration formulation (Prograf®) and with once-daily formulation (Advagraf®)
M. T. Rabuñal Ãlvarez, E. Fernández Gabriel, M. Outeda MacÃas, I. MartÃn Herranz
Ann Transplant 2008; 13(1): 38-38 :: ID: 880199
485 0

01 Jan 2008 :
Evaluation of the Architect and Dimension tacrolimus and cyclosporine assays
P. Wallemacq, J. S. Gofï¬net
Ann Transplant 2008; 13(1): 37-38 :: ID: 880197
530 0

01 Jan 2008 :
Evaluation of the Architect and Dimension tacrolimus and cyclosporine assays
P. Wallemacq, J. S. Gofï¬net, H. Ait-Youcef
Ann Transplant 2008; 13(1): 37-38 :: ID: 880197
530 0

01 Jan 2008 :
Siemens Healthcare Diagnostics immunosuppressive drug monitoring solutions
T. Wei, N. Morjana
Ann Transplant 2008; 13(1): 37-37 :: ID: 880196
530 0

01 Jan 2008 :
Siemens Healthcare Diagnostics immunosuppressive drug monitoring solutions
T. Wei, N. Morjana, S. Goss, L. Bantum, Y. Yue, R. Janzen, G. Siefring
Ann Transplant 2008; 13(1): 37-37 :: ID: 880196
530 0

01 Jan 2008 :
Evaluation of a commercially available whole blood calibrator and control kit for the analysis of cyclosporin A, everolimus, sirolimus and tacrolimus using LC/MS/MS technology
A. M. Taylor, T. N. Gamble
Ann Transplant 2008; 13(1): 36-37 :: ID: 880195
542 0

01 Jan 2008 :
Evaluation of a commercially available whole blood calibrator and control kit for the analysis of cyclosporin A, everolimus, sirolimus and tacrolimus using LC/MS/MS technology
A. M. Taylor, T. N. Gamble, D. Blake, T. Drury, M. Ehrdhard
Ann Transplant 2008; 13(1): 36-37 :: ID: 880195
542 0

01 Jan 2008 :
High throughput LC-MS/MS method for quantitative analysis of immunosuppressant drugs in whole blood using a triple quadrupole LC-MS/MS with an APCI source and implemented on column multiplexing LC system
R. Ruzicka, M. Kozak
Ann Transplant 2008; 13(1): 36-36 :: ID: 880194
515 0

01 Jan 2008 :
High throughput LC-MS/MS method for quantitative analysis of immunosuppressant drugs in whole blood using a triple quadrupole LC-MS/MS with an APCI source and implemented on column multiplexing LC system
R. Ruzicka, M. Kozak, V. Bodepudi, R. Loor, J. Zonderman
Ann Transplant 2008; 13(1): 36-36 :: ID: 880194
515 0

01 Jan 2008 :
Sirolimus measurement by LC-MS/MS without solid phase extraction – overcoming the obstacles
N. W. Brown, P. Arampatzis
Ann Transplant 2008; 13(1): 36-36 :: ID: 880193
568 0

01 Jan 2008 :
Sirolimus measurement by LC-MS/MS without solid phase extraction – overcoming the obstacles
N. W. Brown, P. Arampatzis, C. E. Gonde, M. Pires, J. Tracey, M. Tredger
Ann Transplant 2008; 13(1): 36-36 :: ID: 880193
568 0

29 Sep 2008 :
The role of genetics and pharmacogenetic monitoring in transplantation
M. Masri,
Ann Transplant 2008; 13(1): 35-35 :: ID: 880192
531 0

29 Sep 2008 :
The role of genetics and pharmacogenetic monitoring in transplantation
M. Masri
Ann Transplant 2008; 13(1): 35-35 :: ID: 880192
531 0

01 Jan 2008 :
The CYP3A5*1/*3 single nucleotide polymorphism (SNP) determines the extent of drug interaction between tacrolimus and fluconazole in renal transplant recipients
H. de Jonge, M. Naesens
Ann Transplant 2008; 13(1): 34-35 :: ID: 880191
522 0

01 Jan 2008 :
The CYP3A5*1/*3 single nucleotide polymorphism (SNP) determines the extent of drug interaction between tacrolimus and fluconazole in renal transplant recipients
H. de Jonge, M. Naesens, Y. Vanrenterghem, D. R. Kuypers
Ann Transplant 2008; 13(1): 34-35 :: ID: 880191
522 0

01 Jan 2008 :
In vitro investigation of MRP 2 in the cyclosporine A – pravastatin interplay
R.l Kato, M. Nishide
Ann Transplant 2008; 13(1): 34-34 :: ID: 880190
553 0

01 Jan 2008 :
In vitro investigation of MRP 2 in the cyclosporine A – pravastatin interplay
R.l Kato, M. Nishide, C. Kodzu, Y. Ijiri, K. Tanaka
Ann Transplant 2008; 13(1): 34-34 :: ID: 880190
553 0

01 Jan 2008 :
In vivo hepatic CYP3A4 activity is signiï¬cantly higher in tacrolimus treated vs cyclosporine treated renal transplant recipients
H. de Jonge, M. Naesens
Ann Transplant 2008; 13(1): 34-34 :: ID: 880189
538 0

01 Jan 2008 :
In vivo hepatic CYP3A4 activity is signiï¬cantly higher in tacrolimus treated vs cyclosporine treated renal transplant recipients
H. de Jonge, M. Naesens, K. Verbeke, Y. Vanrenterghem, D. R. Kuypers
Ann Transplant 2008; 13(1): 34-34 :: ID: 880189
538 0

01 Jan 2008 :
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in caucasian liver transplant patients
A. Provenzani, M. Notarbartolo
Ann Transplant 2008; 13(1): 33-33 :: ID: 880188
483 0

01 Jan 2008 :
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in caucasian liver transplant patients
A. Provenzani, M. Notarbartolo, F. Biondi, M. Labbozzetta, P. Poma, G. Vizzini, U. Palazzo, P. Polidori, F. Triolo, B. Gridelli, N. D'Alessandro
Ann Transplant 2008; 13(1): 33-33 :: ID: 880188
483 0

01 Jan 2008 :
The pregnane X receptor C-25385t single nucleotide polymorphism (SNP) does not affect tacrolimus pharmacokinetics in a large cohort of renal transplant recipients
H. de Jonge, M. Naesens
Ann Transplant 2008; 13(1): 33-33 :: ID: 880187
628 0

01 Jan 2008 :
The pregnane X receptor C-25385t single nucleotide polymorphism (SNP) does not affect tacrolimus pharmacokinetics in a large cohort of renal transplant recipients
H. de Jonge, M. Naesens, Y. Vanrenterghem, D. R. Kuypers
Ann Transplant 2008; 13(1): 33-33 :: ID: 880187
628 0

01 Jan 2008 :
Modiï¬ed release formulation in immunotherapy – the tacrolimus case
N. Undre,
Ann Transplant 2008; 13(1): 32-32 :: ID: 880186
508 0

01 Jan 2008 :
Modiï¬ed release formulation in immunotherapy – the tacrolimus case
N. Undre
Ann Transplant 2008; 13(1): 32-32 :: ID: 880186
508 0

01 Jan 2008 :
Generic substitution of immunosuppressive drugs – requirements for an equivalent product
A. Johnston, D. W. Holt
Ann Transplant 2008; 13(1): 31-31 :: ID: 880185
475 0

01 Jan 2008 :
Generic substitution of immunosuppressive drugs – requirements for an equivalent product
A. Johnston, D. W. Holt
Ann Transplant 2008; 13(1): 31-31 :: ID: 880185
475 0

01 Jan 2008 :
Generic products – requirements for drug registration
P. K. Kunicki,
Ann Transplant 2008; 13(1): 30-30 :: ID: 880184
423 0

01 Jan 2008 :
Generic products – requirements for drug registration
P. K. Kunicki
Ann Transplant 2008; 13(1): 30-30 :: ID: 880184
423 0

01 Jan 2008 :
Therapeutic drug monitoring of immunosuppressive drugs – future perspectives
P. Wallemacq,
Ann Transplant 2008; 13(1): 29-29 :: ID: 880183
437 0

01 Jan 2008 :
Therapeutic drug monitoring of immunosuppressive drugs – future perspectives
P. Wallemacq
Ann Transplant 2008; 13(1): 29-29 :: ID: 880183
437 0

01 Jan 2008 :
Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring
D. R. Kuypers,
Ann Transplant 2008; 13(1): 28-28 :: ID: 880182
459 0

01 Jan 2008 :
Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring
D. R. Kuypers
Ann Transplant 2008; 13(1): 28-28 :: ID: 880182
459 0

01 Jan 2008 :
Pharmacokinetics of mycophenolic acid: A comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients
T. van Gelde,
Ann Transplant 2008; 13(1): 27-27 :: ID: 880181
517 0

01 Jan 2008 :
Pharmacokinetics of mycophenolic acid: A comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients
T. van Gelde
Ann Transplant 2008; 13(1): 27-27 :: ID: 880181
517 0

01 Jan 2008 :
Therapeutic drug monitoring of sirolimus and everolimus
E.M. Billaud,
Ann Transplant 2008; 13(1): 26-26 :: ID: 880180
462 0

01 Jan 2008 :
Therapeutic drug monitoring of sirolimus and everolimus
E.M. Billaud
Ann Transplant 2008; 13(1): 26-26 :: ID: 880180
462 0

01 Jan 2008 :
Therapeutic drug monitoring of tacrolimus
P. Wallemacq,
Ann Transplant 2008; 13(1): 25-25 :: ID: 880179
467 0

01 Jan 2008 :
Therapeutic drug monitoring of tacrolimus
P. Wallemacq
Ann Transplant 2008; 13(1): 25-25 :: ID: 880179
467 0

01 Jan 2008 :
Therapeutic drug monitoring of ciclosporin
A. Johnston, D. W. Holt
Ann Transplant 2008; 13(1): 24-24 :: ID: 880178
493 0

01 Jan 2008 :
Therapeutic drug monitoring of ciclosporin
A. Johnston, D. W. Holt
Ann Transplant 2008; 13(1): 24-24 :: ID: 880178
493 0

01 Jan 2008 :
Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the curve in patients receiving concomitant sirolimus or cyclosporine
L. M. Shaw, M. Figurski
Ann Transplant 2008; 13(1): 23-23 :: ID: 880177
425 0

01 Jan 2008 :
Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the curve in patients receiving concomitant sirolimus or cyclosporine
L. M. Shaw, M. Figurski, M. D. Pescovitz
Ann Transplant 2008; 13(1): 23-23 :: ID: 880177
425 0

01 Jan 2008 :
Clinical application of population pharmacokinetic methods developed for immunosuppressive drugs
P. Marquet,
Ann Transplant 2008; 13(1): 22-22 :: ID: 880176
520 0

01 Jan 2008 :
Clinical application of population pharmacokinetic methods developed for immunosuppressive drugs
P. Marquet
Ann Transplant 2008; 13(1): 22-22 :: ID: 880176
520 0

01 Jan 2008 :
What can we learn from proï¬ciency testing of immunosuppressive drug assays?
D. W. Holt, A. Johnston
Ann Transplant 2008; 13(1): 21-21 :: ID: 880175
434 0

01 Jan 2008 :
What can we learn from proï¬ciency testing of immunosuppressive drug assays?
D. W. Holt, A. Johnston
Ann Transplant 2008; 13(1): 21-21 :: ID: 880175
434 0

01 Jan 2008 :
Immunoassays for immunosuppressive drugs – beneï¬ ts and risks
W. Steimer,
Ann Transplant 2008; 13(1): 20-20 :: ID: 880174
546 0

01 Jan 2008 :
Immunoassays for immunosuppressive drugs – beneï¬ ts and risks
W. Steimer
Ann Transplant 2008; 13(1): 20-20 :: ID: 880174
546 0

01 Jan 2008 :
Review of the newest HPLC-MS/MS methods for determination of immunosuppressive drugs in clinical practice
M. Korecka,
Ann Transplant 2008; 13(1): 19-19 :: ID: 880173
443 0

01 Jan 2008 :
Review of the newest HPLC-MS/MS methods for determination of immunosuppressive drugs in clinical practice
M. Korecka
Ann Transplant 2008; 13(1): 19-19 :: ID: 880173
443 0

01 Jan 2008 :
Introduction to high-performance liquid chromatography-tandem mass spectrometry: The gold standard for monitoring immunosuppressive drugs
P. J. Taylor,
Ann Transplant 2008; 13(1): 18-18 :: ID: 880172
826 0

01 Jan 2008 :
Introduction to high-performance liquid chromatography-tandem mass spectrometry: The gold standard for monitoring immunosuppressive drugs
P. J. Taylor
Ann Transplant 2008; 13(1): 18-18 :: ID: 880172
826 0

01 Jan 2008 :
Biomarkers - as an adjunct to immunosuppressive drug monitoring
M. Oellerich,
Ann Transplant 2008; 13(1): 17-17 :: ID: 880171
514 0

01 Jan 2008 :
Biomarkers - as an adjunct to immunosuppressive drug monitoring
M. Oellerich
Ann Transplant 2008; 13(1): 17-17 :: ID: 880171
514 0

01 Jan 2008 :
PK/PD modelling of immunosuppressive agents
E. Wyska,
Ann Transplant 2008; 13(1): 16-16 :: ID: 880170
582 0

01 Jan 2008 :
PK/PD modelling of immunosuppressive agents
E. Wyska
Ann Transplant 2008; 13(1): 16-16 :: ID: 880170
582 0

01 Jan 2008 :
Drug transporters for immunosuppressive agents
I.A.M. MacPhee,
Ann Transplant 2008; 13(1): 15-15 :: ID: 880169
384 0

01 Jan 2008 :
Drug transporters for immunosuppressive agents
I.A.M. MacPhee
Ann Transplant 2008; 13(1): 15-15 :: ID: 880169
384 0

01 Jan 2008 :
Pharmacogenetics in immunotherapy: present knowledge and future perspectives
D. A. Hesselink,
Ann Transplant 2008; 13(1): 13-14 :: ID: 880168
595 0

01 Jan 2008 :
Pharmacogenetics in immunotherapy: present knowledge and future perspectives
D. A. Hesselink
Ann Transplant 2008; 13(1): 13-14 :: ID: 880168
595 0

01 Jan 2008 :
Pharmacokinetic principles of immunosuppressive-drugs
K. Budde, P. Glander
Ann Transplant 2008; 13(1): 12-12 :: ID: 880167
592 0

01 Jan 2008 :
Pharmacokinetic principles of immunosuppressive-drugs
K. Budde, P. Glander
Ann Transplant 2008; 13(1): 12-12 :: ID: 880167
592 0

01 Jan 2008 :
Clinical immunosuppression – current status
M. Klinger,
Ann Transplant 2008; 13(1): 11-11 :: ID: 880166
569 0

01 Jan 2008 :
Clinical immunosuppression – current status
M. Klinger
Ann Transplant 2008; 13(1): 11-11 :: ID: 880166
569 0

01 Jan 2008 :
New insight of immunosuppressive drugs related nephrotoxicity
E. Thervet,
Ann Transplant 2008; 13(1): 10-10 :: ID: 880165
588 0

01 Jan 2008 :
New insight of immunosuppressive drugs related nephrotoxicity
E. Thervet
Ann Transplant 2008; 13(1): 10-10 :: ID: 880165
588 0

01 Jan 2008 :
Organ transplantation in Poland
M. Durlik,
Ann Transplant 2008; 13(1): 9-9 :: ID: 880164
635 0

01 Jan 2008 :
Organ transplantation in Poland
M. Durlik
Ann Transplant 2008; 13(1): 9-9 :: ID: 880164
635 0
In Press
Original article
Simultaneous Liver and Kidney Transplant in a Middle-Income Country: A Single-Center ExperienceAnn Transplant In Press; DOI: 10.12659/AOT.947649
Original article
Outcomes of Combined Liver-Kidney Transplantation in Polycystic Liver and Kidney DiseaseAnn Transplant In Press; DOI: 10.12659/AOT.947639
Most Viewed Current Articles
03 Jan 2023 : Original article 6,872
Impact of Autologous Stem Cell Transplantation on Primary Central Nervous System Lymphoma in First-Line and...DOI :10.12659/AOT.938467
Ann Transplant 2023; 28:e938467
15 Aug 2023 : Review article 6,817
Free-Circulating Nucleic Acids as Biomarkers in Patients After Solid Organ TransplantationDOI :10.12659/AOT.939750
Ann Transplant 2023; 28:e939750
16 May 2023 : Original article 6,561
Breaking Antimicrobial Resistance: High-Dose Amoxicillin with Clavulanic Acid for Urinary Tract Infections ...DOI :10.12659/AOT.939258
Ann Transplant 2023; 28:e939258
28 May 2024 : Original article 5,900
Effect of Dexmedetomidine Combined with Remifentanil on Emergence Agitation During Awakening from Sevoflura...DOI :10.12659/AOT.943281
Ann Transplant 2024; 29:e943281